INTERNATIONAL PATENT: JOHNSON & JOHNSON ENTERPRISE INNOVATION INC. FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITIONS OF AN A2A RECEPTOR ANTAGONIST"

GENEVA, June 23 -- JOHNSON & JOHNSON ENTERPRISE INNOVATION INC. (One Johnson & Johnson PlazaNew Brunswick, New Jersey 08933) filed a patent application (PCT/IB2024/062632) for "PHARMACEUTICAL COMPOSITIONS OF AN A2A RECEPTOR ANTAGONIST" on Dec 13, 2024. With publication no. WO/2025/126137, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHU, Donghua (8F, Building A, Xinyan Mansion, No.65, Guiqing RoadXuhui District, Shanghai 200233), JI, Chongmin (8F, Building A, Xinyan Mansion, No. 65, Guiqing RoadXuhui District, Shanghai...